Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Johnson and Johnson
Harvard Business School
Baxter
Dow

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Hanford Gc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HANFORD GC, and what generic and branded alternatives to HANFORD GC drugs are available?

HANFORD GC has five approved drugs.



Summary for Hanford Gc
US Patents:0
Tradenames:3
Ingredients:3
NDAs:5

Drugs and US Patents for Hanford Gc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hanford Gc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062772-006 Apr 15, 1993 AP RX No No   Start Trial   Start Trial
Hanford Gc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062772-007 Apr 15, 1993 AP RX No No   Start Trial   Start Trial
Hanford Gc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062772-003 Apr 15, 1993 AP RX No No   Start Trial   Start Trial
Hanford Gc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062772-001 Apr 15, 1993 AP RX No No   Start Trial   Start Trial
Hanford Gc PENICILLIN G POTASSIUM penicillin g potassium INJECTABLE;INJECTION 065149-002 Jul 23, 2009 AP RX No No   Start Trial   Start Trial
Hanford Gc AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 065176-002 Nov 30, 2005 AP RX No No   Start Trial   Start Trial
Hanford Gc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062772-008 Apr 15, 1993 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Colorcon
Mallinckrodt
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.